STOCK TITAN
  1. Home
  2. Sec-filings
  3. BIVI
  4. [EFFECT] BIOVIE INC. SEC Filing

[EFFECT] BIOVIE INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 18, 2025
Accession Number: 0001520138-25-000294
Submission Type: POS AM
CIK: 0001580149
Company Name: BIOVIE INC.
File Number: 333-288525

Source: View Original Filing on SEC EDGAR

Stock BIVI logo
Biovie Inc

NASDAQ:BIVI

BIVI Rankings

#6301 Ranked by Market Cap
N/A Ranked by Dividends

BIVI Latest News

Nov 19, 2025
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
Sep 26, 2025
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
Aug 13, 2025
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes
Aug 11, 2025
BioVie Inc. Announces Closing of $12 Million Public Offering
Aug 7, 2025
BioVie Inc. Announces Pricing of $12 Million Public Offering

BIVI Latest SEC Filings

Nov 25, 2025
[S-8] BIOVIE INC. Employee Benefit Plan Registration
Nov 13, 2025
[8-K] BIOVIE INC. Reports Material Event
Nov 12, 2025
[8-K] BIOVIE INC. Reports Material Event
Nov 10, 2025
[10-Q] BIOVIE INC. Quarterly Earnings Report
Oct 28, 2025
[Form 3] BIOVIE INC. Initial Statement of Beneficial Ownership

BIVI Stock Data

10.02M
7.29M
3.28%
1.53%
2.3%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARSON CITY